Migration and invasion in B16‑F10 mouse melanoma cells are regulated by Nrf2 inhibition during treatment with ionizing radiation

Gao,Yali; Zhao,Zishen; Meng,Xiaoyin; Chen,Hongguag; Fu,Guojun

doi:10.3892/ol.2018.8799

Migration and invasion in B16‑F10 mouse melanoma cells are regulated by Nrf2 inhibition during treatment with ionizing radiation

Authors:
- Yali Gao
- Zishen Zhao
- Xiaoyin Meng
- Hongguag Chen
- Guojun Fu
View Affiliations

Affiliations: Department of Radiotherapy, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China, Department of Dermatology, Cangzhou City People's Hospital, Cangzhou, Hebei 061000, P.R. China, Department of Gynaecology and Obstetrics, Tianjin Hospital, Tianjin 300211, P.R. China, Department of Anesthesiology, Tianjin Institute of Anesthesiology, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China
Published online on: May 24, 2018 https://doi.org/10.3892/ol.2018.8799
Pages: 1959-1966

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nuclear factor erythroid 2‑related factor 2 (Nrf2) serves a critical role in carcinogenesis. The present study examined the effect of Nrf2 on the proliferation and invasion of melanoma cells that were treated with ionizing radiation. B16‑F10 mouse melanoma cells were exposed to various doses of ionizing radiation for different time periods. Small interfering (si)RNAs targeting Nrf2 were transfected into B16‑F10 cells, and cell proliferation, invasion and apoptosis were detected by Transwell, MTT or western blot assays. The expression of Nrf2 and its downstream heme oxygenase 1 (HO‑1) was analyzed by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting. HO‑1 activity was also examined. Ionizing radiation stimulated Nrf2 expression, increased caspase‑3 expression, and reduced the viability, migration and invasion of B16‑F10 mouse melanoma cells. Transfection with Nrf2 siRNA was able to inhibit Nrf2 and HO‑1 expression in B16‑F10 mouse melanoma cells that were treated by ionizing radiation. Inhibition of Nrf2 further reduced cell viability, invasion and migration, and elevated caspase‑3 expression in B16‑F10 mice melanoma cells that were treated by ionizing radiation. In summary, treatment with ionizing radiation was able to stimulate Nrf2 expression and regulate cell viability, invasion and migration of B16‑F10 cells. A combination of Nrf2 knockdown and ionizing radiation treatment exerted a synergistic effect on migration, invasion and apoptosis in B16‑F10 murine melanoma cells.

View Figures

View References

1	Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E and Zwarthoff EC: KRAS and BRAF mutation analysis in routine molecular diagnostics: Comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA. J Mol Diagn. 14:247–255. 2012. View Article : Google Scholar : PubMed/NCBI
2	Kanzler MH and Swetter SM: Malignant melanoma. J Am Acad Dermatol. 48:780–783. 2003. View Article : Google Scholar : PubMed/NCBI
3	Streicher KL, Zhu W, Lehmann KP, Georgantas RW, Morehouse CA, Brohawn P, Carrasco RA, Xiao Z, Tice DA, Higgs BW, et al: A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene. 31:1558–1570. 2012. View Article : Google Scholar : PubMed/NCBI
4	Reintgen D, Cruse CW and Atkins M: Cutaneous malignant melanoma. Clin Dermatol. 19:253–261. 2001. View Article : Google Scholar : PubMed/NCBI
5	Serrone L, Zeuli M, Sega FM and Cognetti F: Dacarbazine-based chemotherapy for metastatic melanoma: Thirty-year experience overview. J Exp Clin Cancer Res. 19:21–34. 2000.PubMed/NCBI
6	Alwan LM, Grossmann K, Sageser D, Van Atta J, Agarwal N and Gilreath JA: Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma. Target Oncol. 9:63–71. 2014. View Article : Google Scholar : PubMed/NCBI
7	Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M, et al: High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 17:2105–2116. 1999. View Article : Google Scholar : PubMed/NCBI
8	Li N, Alam J, Venkatesan MI, Eiguren-Fernandez A, Schmitz D, Di Stefano E, Slaughter N, Killeen E, Wang X, Huang A, et al: Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: Protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol. 173:3467–3481. 2004. View Article : Google Scholar : PubMed/NCBI
9	Bütof R, Dubrovska A and Baumann M: Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol. 108:388–396. 2013. View Article : Google Scholar : PubMed/NCBI
10	Baird L, Llères D, Swift S and Dinkova-Kostova AT: Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci USA. 110:15259–15264. 2013. View Article : Google Scholar : PubMed/NCBI
11	Canning P, Sorrell FJ and Bullock AN: Structural basis of KEAP1 interactions with Nrf2. Free Radic Biol Med. 91:101–107. 2015. View Article : Google Scholar
12	Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn J and Song JY: An effective strategy for increasing the radiosensitivity of human lung cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radic Biol Med. 53:807–816. 2012. View Article : Google Scholar : PubMed/NCBI
13	Mcdonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, Lagadec C, Della Donna L, Ratikan J, Szelag H, Hlatky L and McBride WH: Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res. 70:8886–8895. 2010. View Article : Google Scholar : PubMed/NCBI
14	Singh A, Bodas M, Wakabayashi N, Bunz F and Biswal S: Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal. 13:1627–1637. 2010. View Article : Google Scholar : PubMed/NCBI
15	Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M and Hirohashi S: Cancer related mutations in NRF2 impair its recognition by Keap1-Cu13 E3 ligase and promote malignancy. Proc Natl Acad Sci USA. 105:13568–13573. 2008. View Article : Google Scholar : PubMed/NCBI
16	Zhao Q, Mao A, Yan J, Sun C, Di C, Zhou X, Li H, Guo R and Zhang H: Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells. Int J Oncol. 48:765–773. 2016. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Konrad FM, Zwergel C, Ngamsri KC and Reutershan J: Anti-inflammatory effects of heme oxygenase-1 depend on adenosine A2A- and A2B-receptor signaling in acute pulmonary inflammation. Front Immunol. 8:18742017. View Article : Google Scholar : PubMed/NCBI
19	Gęgotek A and Skrzydlewska E: The role of transcription factor Nrf2 in skin cells metabolism. Arch Dermatol Res. 307:385–396. 2015. View Article : Google Scholar : PubMed/NCBI
20	Jeayeng S, Wongkajornsilp A, Slominski AT, Jirawatnotai S, Sampattavanich S and Panich U: Nrf2 in keratinocytes modulates UVB-induced DNA damage and apoptosis in melanocytes through MAPK signaling. Free Radic Biol Med. 108:918–928. 2017. View Article : Google Scholar : PubMed/NCBI
21	Rana T, Schultz MA, Freeman ML and Biswas S: Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL. Free Radic Biol Med. 53:2298–2307. 2012. View Article : Google Scholar : PubMed/NCBI
22	Bravo-Cordero JJ, Hodgson L and Condeelis J: Directed cell invasion and migration during metastasis. Curr Opin Cell Biol. 24:277–283. 2012. View Article : Google Scholar : PubMed/NCBI
23	Khan N and Mukhtar H: Cancer and metastasis: Prevention and treatment by green tea. Cancer Metastasis Rev. 29:435–445. 2010. View Article : Google Scholar : PubMed/NCBI
24	Wu ZY, Lien JC, Huang YP, Liao CL, Lin JJ, Fan MJ, Ko YC, Hsiao YP, Lu HF and Chung JG: Casticin inhibits A375.S2 human melanoma cell migration/invasion through downregulating NF-κB and matrix metalloproteinase-2 and −1. Molecules. 21:3842016. View Article : Google Scholar : PubMed/NCBI
25	Guo Y, Hu B, Huang H, Tsung A, Gaikwad NW, Xu M, Jiang M, Ren S, Fan J, Billiar TR, et al: Estrogen sulfotransferase is an oxidative stress responsive gene that gender-specifically affects liver ischemia/reperfusion injury. J Biol Chem. 290:14754–14764. 2015. View Article : Google Scholar : PubMed/NCBI
26	Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K and Yamamoto M: Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 7:116242016. View Article : Google Scholar : PubMed/NCBI
27	Geismann C, Arlt A, Sebens S and Schäfer H: Cytoprotection ‘gone astray’: Nrf2 and its role in cancer. Onco Targets Ther. 7:1497–1518. 2014.PubMed/NCBI
28	Hayes JD and McMahon M: NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer. Trends Biochem Sci. 34:176–188. 2009. View Article : Google Scholar : PubMed/NCBI
29	Ferrándiz ML, Nacher-Juan J and Alcaraz MJ: Nrf2 as a therapeutic target for rheumatic diseases. Biochem Pharmacol. 13:338–346. 2018. View Article : Google Scholar
30	Tsukimoto M, Tamaishi N, Homma T and Kojima S: Low-dose gamma-ray irradiation induces translocation of Nrf2 into nuclear in mouse macrophage RAW264.7 cells. J Radiat Res. 51:349–353. 2010. View Article : Google Scholar : PubMed/NCBI
31	Meng D, Wang X, Chang Q, Hitron A, Zhang Z, Xu M, Chen G, Luo J, Jiang B, Fang J and Shi X: Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol Appl Pharmacol. 244:291–299. 2010. View Article : Google Scholar : PubMed/NCBI
32	Pan H, Wang H, Zhu L, Mao L, Qiao L and Su X: The role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg. 80:363–370. 2013. View Article : Google Scholar : PubMed/NCBI
33	Menegon S, Columbano A and Giordano S: The dual roles of NRF2 in cancer. Trends Mol Med. 22:578–593. 2016. View Article : Google Scholar : PubMed/NCBI